Jean-Yves Bonnefoy

Jean-Yves Bonnefoy has extensive work experience in the biotechnology industry. Jean-Yves is currently the CEO and Co-Founder of Salto Therapeutics starting in August 2022. Prior to this, they owned their own consulting company, JYBConsultant, since October 2013. Jean-Yves has also served as the President of Syndivia since March 2014. From April 2015 to December 2022, they held the positions of President & CEO and CEO at Anagenesis Biotechnologies. Additionally, they were the President & CEO of ALMS THERAPEUTICS from September 2017 to December 2018. Previously, they served as the President of Alsace BioValley from June 2010 to July 2014. Jean-Yves was also the CEO of ElsaLys Biotech from July 2013 to January 2014. Prior to these roles, they held the position of VP, R&D at TRANSGENE from February 2005 to June 2013.

Jean-Yves Bonnefoy attended Université Claude Bernard Lyon 1, but the specific details regarding their degree, field of study, start, and end dates are not provided.